Literature DB >> 12499455

Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data.

S Luo1, X Liu, S Mu, S P Tsai, C P Wen.   

Abstract

BACKGROUND: Scattered patches of crocidolite, one form of asbestos, were found in the surface soil in the rural county of Da-yao in southwestern China. In 1983, researchers from the West China University of Medical Sciences (WCUMS) discovered that residents of two villages in Da-yao had hyperendemic pleural plaques and excessive numbers of pleural mesotheliomas. AIMS: To review and summarise epidemiological studies, along with other relevant data, and to discuss the potential contribution to environmental risk assessment.
METHODS: This report is based on a review of several clinical/epidemiological studies conducted by WCUMS researchers since 1984, which included one cross sectional medical examination survey, one clinical/pathological analysis of 46 cases of mesothelioma, and three retrospective cohort mortality studies. Additional information acquired from reviewing original data first hand during a personal visit along with an interview of medical specialists from Da-yao County Hospital was also incorporated.
RESULTS: The prevalence of pleural plaque was 20% among peasants in Da-yao over 40 years of age in the cross sectional survey. The average number of mesothelioma cases was 6.6 per year in the 1984-95 period and 22 per year in the 1996-99 period, in a population of 68 000. For those mesothelioma cases that were histology confirmed, there were 3.8 cases/year in the first period and 9 cases/year in the second. Of the 2175 peasants in this survey, 16 had asbestosis. Lung cancer deaths were significantly increased in all three cohort studies. The annual mortality rate for mesothelioma was 85 per million, 178 per million, and 365 per million for the three cohort studies, respectively. The higher exposed peasants had a fivefold increased mesothelioma mortality compared to their lower exposed counterparts. There were no cases of mesothelioma in the comparison groups where no crocidolite was known to exist in the environment. In the third cohort study, almost one of five cancer deaths (22%) was from mesothelioma. The ratio of lung cancer to mesothelioma deaths was low for all three studies (1.3, 3.0, and 1.2, respectively).
CONCLUSIONS: The observation of numerous mesothelioma cases at Da-yao was a unique finding, due mainly to their lifetime exposure to crocidolite asbestos. The finding of cases dying at a younger age and the relatively high ratio of mesothelioma cases to lung cancer could also be another unique result of lifetime environmental exposure to crocidolite asbestos. Although the commercial use of crocidolite has been officially banned since 1984, the incidence of mesothelioma has continued to show a steady increase, particularly among peasants. Since the latency of mesothelioma is approximately 30-40 years, the ban had little effect in the 1990s. The increased awareness and changes in diagnosis over time may also contribute to the increase. Furthermore, exposure to asbestos stoves and walls continued. The government implemented reduction of these exposures. However, from a public health standpoint, the most important issue is the complete avoidance of further exposure to asbestos.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499455      PMCID: PMC1740384          DOI: 10.1136/oem.60.1.35

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  22 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

Review 2.  The epidemiology of mesothelioma in historical context.

Authors:  J C McDonald; A D McDonald
Journal:  Eur Respir J       Date:  1996-09       Impact factor: 16.671

3.  Asbestos--still a carcinogen.

Authors:  P J Landrigan
Journal:  N Engl J Med       Date:  1998-05-28       Impact factor: 91.245

Review 4.  Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice.

Authors:  M R Becklake
Journal:  Am Rev Respir Dis       Date:  1976-07

5.  Mortality experience of insulation workers in the United States and Canada, 1943--1976.

Authors:  I J Selikoff; E C Hammond; H Seidman
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

6.  Dose-response relationships for asbestos-related disease: implications for hygiene standards. Part II. Mortality.

Authors:  J Peto
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

7.  Smoking in China: findings of the 1996 National Prevalence Survey.

Authors:  G Yang; L Fan; J Tan; G Qi; Y Zhang; J M Samet; C E Taylor; K Becker; J Xu
Journal:  JAMA       Date:  1999-10-06       Impact factor: 56.272

8.  Risk of asbestosis in crocidolite and amosite mines in South Africa.

Authors:  L M Irwig; R S du Toit; G K Sluis-Cremer; A Solomon; R G Thomas; P P Hamel; I Webster; T Hastie
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 9.  Asbestos exposure--quantitative assessment of risk.

Authors:  J M Hughes; H Weill
Journal:  Am Rev Respir Dis       Date:  1986-01

10.  Occupational and environmental mesotheliomas due to crocidolite mining activities in Wittenoom, Western Australia.

Authors:  A Rogers; M Nevill
Journal:  Scand J Work Environ Health       Date:  1995-08       Impact factor: 5.024

View more
  18 in total

1.  High-risk mesothelioma relation to meteorological and geological condition and distance from naturally occurring asbestos.

Authors:  Abdurrahman Abakay; Abdullah Cetin Tanrikulu; Mustafa Ayhan; Mehmet Sefik Imamoglu; Mahsuk Taylan; Muhammet Ali Kaplan; Ozlem Abakay
Journal:  Environ Health Prev Med       Date:  2015-12-21       Impact factor: 3.674

Review 2.  Environmental asbestos exposure and risk of mesothelioma.

Authors:  Curtis W Noonan
Journal:  Ann Transl Med       Date:  2017-06

3.  New comprehensive approach for airborne asbestos characterisation and monitoring.

Authors:  Miroslav Klán; Petra Pokorná; David Havlíček; Ondřej Vik; Martin Racek; Jiří Plocek; Jan Hovorka
Journal:  Environ Sci Pollut Res Int       Date:  2018-08-30       Impact factor: 4.223

4.  Improving the Accuracy of Mesothelioma Diagnosis in China.

Authors:  Zhenying Guo; Michele Carbone; Xing Zhang; Dan Su; Wenyong Sun; Jianlin Lou; Zhibin Gao; Dichu Shao; Junqiang Chen; Gu Zhang; Jinlin Hu; Kaiyan Chen; Fang Wang; Harvey I Pass; Herbert Yu; Andrea Napolitano; Haining Yang; Weimin Mao
Journal:  J Thorac Oncol       Date:  2016-12-19       Impact factor: 15.609

Review 5.  People, planet and profit: Unintended consequences of legacy building materials.

Authors:  Anthony T Zimmer; HakSoo Ha
Journal:  J Environ Manage       Date:  2017-12-15       Impact factor: 6.789

6.  Pleural plaques related to "take-home" exposure to asbestos: An international case series.

Authors:  Alon Peretz; Victor C Van Hee; Mordechai R Kramer; Silvio Pitlik; Matthew C Keifer
Journal:  Int J Gen Med       Date:  2008-11-30

Review 7.  The health impact of nonoccupational exposure to asbestos: what do we know?

Authors:  Marcel Goldberg; Danièle Luce
Journal:  Eur J Cancer Prev       Date:  2009-11       Impact factor: 2.497

Review 8.  Mesothelioma epidemiology, carcinogenesis, and pathogenesis.

Authors:  Haining Yang; Joseph R Testa; Michele Carbone
Journal:  Curr Treat Options Oncol       Date:  2008-08-15

9.  Health implications of atmospheric aerosols from asbestos-bearing road pavements traditionally used in Southern Brazil.

Authors:  Ricardo H M Godoi; Sérgio J Gonçalves; Célia Sayama; Gabriela Polezer; José M Reis Neto; Bálint Alföldy; René Van Grieken; Carlos A Riedi; Carlos I Yamamoto; Ana F L Godoi; László Bencs
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-28       Impact factor: 4.223

Review 10.  Overview of asbestos issues in Korea.

Authors:  Hyoung Ryoul Kim
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.